Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term Debt
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mainz Biomed N.V (MYNZ) Accounts Payables: 2020-2025

Historic Accounts Payables for Mainz Biomed N.V (MYNZ) over the last 1 years, with Jun 2025 value amounting to $596,886.

  • Mainz Biomed N.V's Accounts Payables fell 63.89% to $596,886 in Q2 2025 from the same period last year, while for Jun 2025 it was $596,886, marking a year-over-year decrease of 63.89%. This contributed to the annual value of $1.3 million for FY2024, which is 60.61% down from last year.
  • Mainz Biomed N.V's Accounts Payables amounted to $596,886 in Q2 2025, which was down 52.41% from $1.3 million recorded in Q4 2024.
  • In the past 5 years, Mainz Biomed N.V's Accounts Payables ranged from a high of $3.2 million in Q4 2023 and a low of $503,181 during Q2 2022.
  • Its 3-year average for Accounts Payables is $1.7 million, with a median of $1.5 million in 2023.
  • Its Accounts Payables has fluctuated over the past 5 years, first spiked by 445.23% in 2023, then tumbled by 63.89% in 2025.
  • Mainz Biomed N.V's Accounts Payables (Quarterly) stood at $784,786 in 2021, then surged by 246.24% to $2.7 million in 2022, then climbed by 17.19% to $3.2 million in 2023, then plummeted by 60.61% to $1.3 million in 2024, then slumped by 63.89% to $596,886 in 2025.
  • Its Accounts Payables stands at $596,886 for Q2 2025, versus $1.3 million for Q4 2024 and $1.7 million for Q2 2024.